CIAS
TEVA icon

Capital Investment Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Capital Investment Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-938
Closed -$6K – 1180
2019
Q3 		$6K Sell
938
-1,534
-62% -$11.8K ﹤0.01% 1104
2019
Q2 		$19K Sell
2,472
-600
-20% -$7.24K 0.01% 800
2019
Q1 		$48K Sell
3,072
-559
-15% -$9.86K 0.02% 489
2018
Q4 		$56K Buy
+3,631
New +$74.4K 0.02% 436

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Capital Investment Advisory Services's TEVA Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 938 shares — an estimated $6K sold.

Capital Investment Advisory Services first reported a position in TEVA in Q4 2018 and held it in 4 quarters. The position peaked at $56K in Q4 2018. 436 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 938 Teva Pharmaceuticals shares in Q4 2019, an estimated $6K.
  • Capital Investment Advisory Services first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's Teva Pharmaceuticals position peaked at $56K in Q4 2018.
  • 436 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.